Evidence map›Paper›PMID 41035791›Full record

ArticleJCEM case reports2025

A Rare Cause of Thyrotoxicosis: Metastasis of Ovarian Clear Cell Carcinoma to the Thyroid Gland.

Berk Celik, Ajaz Banka

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Berk CelikDepartment of Internal Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, MI 48073, USA.ORCID https://orcid.org/0000-0002-5364-8500
Ajaz BankaDivision of Endocrinology, Department of Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, MI 48073, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastases to the thyroid gland are rare, accounting for up to 2% of all thyroid malignancies. Ovarian cancer metastasizing to the thyroid is exceedingly uncommon, with only a few cases reported in the literature. We present the case of a 36-year-old female individual with a history of metastatic ovarian clear cell carcinoma and known thyroid metastasis who presented with shortness of breath, dysphagia, and palpitations. Laboratory evaluation revealed undetectable thyroid-stimulating hormone (TSH), elevated free thyroxine (fT4) and triiodothyronine (fT3), and markedly increased serum thyroglobulin levels. A computed tomography (CT) scan of the neck demonstrated diffuse thyroid infiltration with compressive features. The patient was diagnosed with thyrotoxicosis and treated with methimazole, prednisone, and metoprolol. To our knowledge, this is the first reported case of ovarian clear cell carcinoma with thyroid gland metastasis presenting with concomitant thyrotoxicosis. Although thyroid metastases are rare and typically nonfunctional, they should be considered in patients with known malignancy who develop new thyroid dysfunction, particularly when biochemical or imaging findings are atypical for thyroiditis or autoimmune thyroid disease. Recognizing this entity is important, as timely distinction from more common causes of thyrotoxicosis can guide appropriate, patient-centered management.

Indexed as

ovarian clear cell carcinomathyroid metastasisthyrotoxicosis

Identifiers

PMID41035791
PMCPMC12480210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.